Pregled bibliografske jedinice broj: 1042062
Azithromycin-loaded liposomes for the treatment of sexually-transmitted infections: anti- chlamydial and biocompatibility studies
Azithromycin-loaded liposomes for the treatment of sexually-transmitted infections: anti- chlamydial and biocompatibility studies // 6th International Symposium on Phospholipids in Pharmaceutical Research
Heidelberg, Njemačka, 2019. str. 86-86 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1042062 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Azithromycin-loaded liposomes for the treatment of sexually-transmitted infections: anti- chlamydial and biocompatibility studies
Autori
Vanić, Željka ; Bogdanov, Anita ; Raffai, Timea ; Uzelac, Lidija ; Rukavina, Zora ; Virok, Dezso Peter ; Kralj, Marijeta ; Škalko-Basnet, Nataša
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
6th International Symposium on Phospholipids in Pharmaceutical Research
/ - , 2019, 86-86
Skup
6th International Symposium on Phospholipids in Pharmaceutical Research
Mjesto i datum
Heidelberg, Njemačka, 09.09.2019. - 10.09.2019
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Chlamydia trachomatis ; Vaginal drug delivery ; Cervical cells ; Deformable liposomes ; Propylene glycol liposomes ; Azithromycin
Sažetak
This study aimed to determine anti-chlamydial activity of the several types of azithromycin (AZI)-loaded liposomes as well as their compatibility with cervical HeLa cells. Propylene glycol AZI-liposomes (PGLs) and deformable propylene glycol AZI-liposomes (DPGLs) were prepared by polyol dilution method, while conventional AZI-liposomes (CLs) were prepared by proliposome method [1]. Following physical characterization at mimicked cervical conditions, all the liposomes were tested against intracellular C. trachomatis. The infected HeLa cells were treated with the different AZI-liposomes or AZI-solution (control), and the anti-chlamydial effect was assessed by determining minimum inhibitory concentrations (MICs) using direct quantitative polymerase chain reactions (qPCR) measurements [2]. The in vitro biocompatibilities of AZI- liposomes were evaluated by MTT test following incubation of the liposomes with the HeLa cells during 24 hours. All AZI-liposomes were negatively surface charged and in the size range 195-270 nm. PGLs and particularly DPGLs were characterized with elastic (deformable) bilayers, while bilayers of CLs were quite rigid due to the presence of hydrogenated phospholipids. In vitro antibacterial studies showed that DPGLs were the most potent against intracellular C. trachomatis with MIC value of 0.0312 µg AZI/ml, followed by PGLs (0.0625 µg AZI/ml) and CLs (0.125 µg AZI/ml). The performed biocompatibility studies proved that all the AZI-liposomes were biocompatible with the HeLa cells. Even at the highest tested AZI concentration (39.5 µg/ml), the viability of the cells remained above 70%. The performed studies indicate the influence of bilayer elasticity/rigidity of AZI-liposomes on tolerability with the cervical cells and anti- chlamydial activity.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb
Profili:
Nataša Škalko-Basnet
(autor)
Zora Rukavina
(autor)
Lidija Uzelac
(autor)
Marijeta Kralj
(autor)
Željka Vanić
(autor)